Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
G Mining Delivers Robust Feasibility Study for High-Grade Oko West Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vg Life Sciences Inc VGLS

Healthcare Biotechnology
VG Life Sciences Inc. is engaged in research and development of therapeutic and diagnostic pharmaceutical and medical products. The Company is focused on restructuring its business to pursue real estate acquisitions, development, and value-added development, resource mining and processing. The Company has not generated any revenue.

Recent & Breaking News (OTCPK:VGLS)

VG Life Sciences Notes Major Achievements and New Grants in Third Quarter 2015

PR Newswire October 8, 2015

VG Life Sciences Granted Combination Cancer Drug Patent

PR Newswire June 22, 2015

VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015

PR Newswire June 16, 2015

VG Life Sciences Granted Key Composition of Matter Patent

GlobeNewswire March 2, 2015

VG Life Sciences Announces Issuance of Patent Covering Treatment of Inflammatory Bowel Disease with Clip-Inducing Agent

GlobeNewswire January 29, 2015

VGLS Q4 2014 Shareholder Update Letter

GlobeNewswire January 14, 2015

New Data Implicate Components of Adaptive Immunity in Traumatic Brain Injury

GlobeNewswire October 20, 2014

VG Life Sciences Inc. Announces Upgrading to OTCQB Marketplace

GlobeNewswire October 16, 2014

VG LIFE SCIENCES, INC. ANNOUNCES SEC FORM 10 REVIEW COMPLETE

GlobeNewswire October 14, 2014

VG Life Sciences' Advisor Gives Preeclampsia Presentation at American Heart Association Conference

GlobeNewswire September 12, 2014

VG Life Sciences Inc. Progress Update Phase I Cancer Study

GlobeNewswire September 4, 2014

VG Life Sciences, Inc. Announces Filing of Form 10 with the SEC.

GlobeNewswire June 23, 2014

Q1 2014 Shareholder Update Letter

GlobeNewswire May 13, 2014

VG Life Sciences Inc. Moves to Restore Financial Accountability & Completes Prior Year Audits, Plans to File Form 10

GlobeNewswire May 1, 2014

VG Life Sciences, Inc.'s Reports on Clinical Outcomes in Phase I Cancer Study

GlobeNewswire March 14, 2014

VG Life Sciences, Inc. Increases Authorized Shares

Globe Newswire January 3, 2014

VG Life Sciences, Inc. Announces the Initiation of IND-Enabling Animal Safety Studies

PR Newswire November 4, 2013

VG Life Sciences Starts Prior Year Audit to Increase Financial Accountability

PR Newswire October 16, 2013

VG Life Sciences, Inc. $2,235,000 Private Placement

PR Newswire October 3, 2013

VG Life Sciences, Inc. Closes on $2,235,000 from Private Fund

PR Newswire October 2, 2013